An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covid.

Social wellbeing scores (borderline significant at the end of treatment p = 0.045) and physical wellbeing scores (not significant at the end of treatment p = 0.64) reduced from baseline to after the first round of chemotherapy but increased to above baseline levels at the end of the study treatment.

also in 11,409 other papers